The Federal Trade Commission said the transaction had threatened to raise prices and stifle innovation for cataract laser eye ...

When Novartis said in June that it would spin off its long-struggling eye-care unit, Alcon, CEO Vas Narasimhan declined to estimate what the valuation on such a transaction might be. But his ...

Alcon demonstrates potential resilience vs. market shocks, with favorable balance sheet risk and positive EPS forecasts for FY26. Read why ALC stock is a Buy.

More than half a decade after it began, a class-action lawsuit accusing several contact lens manufacturers of anticompetitive price fixing has finally come to a close. The case ended with Alcon and ...

SINKING SPRING, Pa. -- It was another steady quarterly report by Alcon, the Switzerland-based eyecare company with manufacturing and research facilities in Berks County. The company mostly beat ...